- Home
- IMTE vs VRAX Comparison
IMTE vs VRAX Comparison
Compare IMTE & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMTE | VRAX |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Australia | United Kingdom |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.7M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMTE | VRAX |
|---|---|---|
| Price | $0.62 | $0.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 103.2K | ★ 191.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $0.19 |
| 52 Week High | $3.17 | $1.58 |
Technical Indicators
Market Signals| Indicator | IMTE | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 41.10 |
| Support Level | $0.50 | $0.20 |
| Resistance Level | $0.82 | $0.25 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 29.17 | 27.00 |
Price Performance
Historical ComparisonAbout IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is mainly engaged in the business of manufacture and sale of nano-coated plates for filters, the manufacture and sale of electronic glass, Halal certification and distribution of Halal products, and new energy products and services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.